Last reviewed · How we verify
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain in Opioid-Tolerant Patients With Chronic Low Back Pain
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain in Opioid-Tolerant Patients with Chronic Low Back Pain
Details
| Lead sponsor | Cephalon |
|---|---|
| Phase | Phase 3 |
| Status | COMPLETED |
| Start date | 2005-09 |
Conditions
- Chronic Low Back Pain
Interventions
- ORAVESCENT Fentanyl Citrate
Countries
United States